Full Description
Authoritative, up-to-date guide to current protocols surrounding the identification and control of infectious diseases
Communicable Disease Control and Health Protection Handbook provides practical advice for specific situations and the important background knowledge that underlies communicable disease control activities. The book, designed to be concise and accessible, explains topics ranging from basic principles to recent changes and innovations in health protection practice. Major syndromes and individual infections are insightfully addressed, as well as an outline of the World Health Organization's international health regulations and the organizational arrangements in place in all European Union nations. This Fifth Edition has been thoroughly revised to capture new developments in the area, especially those following the COVID-19 pandemic.
Communicable Disease Control and Health Protection Handbook includes information on:
Meningitis and meningism, gastrointestinal infection, community acquired pneumonia, rash in pregnancy, rash and fever in children, and illness in returning travelers
Amoebic dysentery, anthrax, botulism, chickenpox and shingles, chlamydia trachomatis, and cholera
Managing incidents and outbreaks, community infection control, hospital infection control, antimicrobial stewardship, and risks to and from healthcare workers
Prevention of blood-borne infections, migrant and refugee health, managing acute chemical and radiation incidents, and global health security
Communicable Disease Control and Health Protection Handbook is an essential reference for public health professionals working in communicable disease control and health protection, public health physicians, epidemiologists, public health nurses, infection control nurses, environmental health officers, microbiologists, policy makers, and general practitioners.
Contents
About the Authors, ix
Foreword, xi
List of Abbreviations, xiii
Section A: Basic concepts
A.1 How to use this book, 3
A.2 Basic concepts in the epidemiology and control of infectious diseases, 4
A.3 Basic concepts in the prevention of infection, 9
A.4 Emergency risk communication, 13
A.5 Health protection on call, 15
Section B: Syndromes
B.1 Meningitis and meningism, 23
B.2 Gastrointestinal infection, 26
B.3 Community-acquired pneumonia, 32
B.4 Rash in pregnancy, 35
B.5 Rash and fever in children, 36
B.6 Illness in returning travellers, 38
B.7 Jaundice, 40
B.8 Infection in the immunocompromised, 41
Section C: Diseases
C.1 Amoebic dysentery, 47
C.2 Anthrax, 48
C.3 Bacillus cereus, 51
C.4 Botulism, 52
C.5 Brucellosis, 56
C.6 Campylobacter, 58
C.7 Chickenpox and shingles (varicella zoster infections), 62
C.8 Chikungunya, 64
C.9 Chlamydophila pneumoniae, 66
C.10 Chlamydia trachomatis, 67
C.11 Cholera, 69
C.12 CJD and other human transmissible spongiform encephalopathies, 71
C.13 Clostridioides difficile, 74
C.14 Clostridium perfringens, 76
C.15 Coronavirus (excluding COVID-19), 78
C.16 COVID-19, 81
C.17 Cryptosporidiosis, 84
C.18 Cyclosporiasis, 88
C.19 Cytomegalovirus, 89
C.20 Dengue fever, 91
C.21 Diphtheria, 92
C.22 Enterococci, including glycopeptide-resistant enterococci, 95
C.23 Enterovirus infections (including hand, foot and mouth disease), 96
C.24 Epstein-Barr virus, 98
C.25 Giardiasis, 100
C.26 Gram-negative bacteraemia (including carbapenem-resistant enterobacterales), 102
C.27 Gonorrhoea, syphilis and other acute STIs, 107
C.28 Hantavirus, 113
C.29 Head lice, 114
C.30 Helicobacter pylori, 116
C.31 Hepatitis A, 117
C.32 Hepatitis B, 120
C.33 Hepatitis C, 123
C.34 Delta hepatitis, 125
C.35 Hepatitis E, 126
C.36 Herpes simplex, 127
C.37 Haemophilus influenzae type b (Hib), 129
C.38 HIV and AIDS, 131
C.39 Influenza, 136
C.40 Japanese B encephalitis, 141
C.41 Legionellosis, 141
C.42 Leprosy, 145
C.43 Leptospirosis, 146
C.44 Listeriosis, 148
C.45 Lyme disease (borreliosis), 150
C.46 Malaria, 152
C.47 Measles, 154
C.48 Meningococcal infection, 156
C.49 Meticillin-resistant Staphylococcus aureus (MRSA), 160
C.50 Mumps, 163
C.51 Mycoplasma pneumoniae, 165
C.52 Norovirus, 166
C.53 Paratyphoid fever, 169
C.54 Parvovirus B19 (fifth disease), 172
C.55 Plague, 173
C.56 Pneumococcal infection, 175
C.57 Poliomyelitis, 178
C.58 Psittacosis, 180
C.59 Q fever, 182
C.60 Rabies, 184
C.61 Relapsing Fever, 186
C.62 Respiratory Syncytial Virus (RSV), 187
C.63 Ringworm, 189
C.64 Rotavirus, 193
C.65 Rubella, 194
C.66 Salmonellosis, 196
C.67 Scabies, 199
C.68 Schistosomiasis, 202
C.69 Shigellosis, 204
C.70 Shiga Toxin-Producing Escherichia coli (STEC) and Other Diarrhoeagenic E. coli, 207
C.71 Smallpox and mpox, 212
C.72 Staphylococcal food poisoning, 217
C.73 Streptococcal infections, 218
C.74 Tetanus, 220
C.75 Threadworms, 222
C.76 Tickborne encephalitis, 223
C.77 Toxocariasis, 224
C.78 Toxoplasmosis, 225
C.79 Tuberculosis (and non-tuberculous mycobacteria), 227
C.80 Tularaemia, 235
C.81 Typhoid fever, 237
C.82 Vibrio parahaemolyticus infection, 239
C.83 Viral haemorrhagic fevers, including Ebola, 241
C.84 Warts and verrucae, 244
C.85 West Nile virus, 246
C.86 Whooping cough, 247
C.87 Yellow fever, 250
C.88 Yersiniosis, 251
C.89 Zika virus infection, 253
C.90 Rare diseases, 256
C.90.1 Bacteria, 256
C.90.2 Rickettsial infections (incl. Typhus) Ehrlichia and Bartonella, 256
C.90.3 Viruses, 263
C.90.4 Protozoa, 263
C.90.5 Helminths, 263
C.90.6 Fungi and actinomycetes, 271
C.90.7 Bites, stings and venoms, 282
C.90.8 Chemical foodborne illness, 283
Section D: Health protection services and functions
D.1 Surveillance of communicable disease, 287
D.2 Managing infectious disease incidents and outbreaks, 293
D.3 Community infection control, 299
D.4 Hospital infection control, 304
D.5 Antimicrobial stewardship, 309
D.6 Risks to and from healthcare workers, 312
D.7 Immunisation services, 316
D.8 Coordination of sexual health services, 320
D.9 Prevention of bloodborne viral infections, 322
D.10 Coordination of services for tuberculosis control, 326
D.11 Travel health, 328
D.12 Migrant and refugee health, 331
D.13 Emergency preparedness planning and response, 334
D.14 Non-infectious environmental hazards, 336
D.15 Managing acute chemical incidents, 342
D.16 Managing acute radiation incidents, 345
D.17 Deliberate release of biological, chemical or radiological hazards, 348
D.18 Clinical governance and audit, 356
D.19 Global health security, 359
Section E: Organizational arrangements
E.1 WHO and International Health Regulations, 365
E.2 Collaboration within the European Union, 367
E.3 Detailed national example: Organisational arrangements for health protection, England, 2025, 369
E.4 Austria, 374
E.5 Belgium, 375
E.6 Bulgaria, 375
E.7 Croatia, 376
E.8 Cyprus, 377
E.9 Czech Republic, 377
E.10 Denmark, 378
E.11 Estonia, 379
E.12 Finland, 379
E.13 France, 380
E.14 Germany, 381
E.15 Greece, 382
E.16 Hungary, 382
E.17 Iceland, 383
E.18 Ireland, 384
E.19 Italy, 385
E.20 Latvia, 385
E.21 Lithuania, 386
E.22 Luxembourg, 387
E.23 Malta, 388
E.24 The Netherlands, 388
E.25 Norway, 389
E.26 Poland, 390
E.27 Portugal, 391
E.28 Romania, 391
E.29 Slovakia, 392
E.30 Slovenia, 393
E.31 Spain, 394
E.32 Sweden, 395
E.33 Switzerland, 395
E.34 United Kingdom, 396
Index, 399
-
- 電子書籍
- 坂月さかな作品集 プラネタリウム・ゴー…
